Cancer Research Aziza Shad EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fraser, M. M.
Right arrow Articles by Baker, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fraser, M. M.
Right arrow Articles by Baker, S. J.
[Cancer Research 64, 7773-7779, November 1, 2004]
© 2004 American Association for Cancer Research

Regular Articles

Pten Loss Causes Hypertrophy and Increased Proliferation of Astrocytes In vivo

Melissa M. Fraser1, Xiaoyan Zhu1, Chang-Hyuk Kwon1,2, Erik J. Uhlmann3, David H. Gutmann3 and Suzanne J. Baker1

1 Department of Developmental Neurobiology, St. Jude Children’s Research Hospital, Memphis, Tennessee; 2 Center for Developmental Biology, University of Texas Southwestern Medical Center of Dallas, Dallas, Texas; and 3 Department of Neurology, Washington University School of Medicine, St. Louis, Missouri

Somatic mutations of PTEN are found in many types of cancers including glioblastoma, the most malignant astrocytic tumor. PTEN mutation occurs in 25 to 40% of glioblastomas but is rarely observed in low-grade glial neoplasms. To determine the role of Pten in astrocytes and glial tumor formation, we inactivated Pten by a Cre-loxP approach with a GFAP-cre transgenic mouse that induced Cre-mediated recombination in astrocytes. Pten conditional knockout mice showed a striking progressive enlargement of the entire brain. Increased nuclear and soma size was observed in both astrocytes and neurons, which contributed in part to the increase in brain size. Pten-deficient astrocytes showed accelerated proliferation in vitro and aberrant ongoing proliferation in adult brains in vivo. In contrast, neurons lacking Pten did not show alterations in proliferation. This study shows cell-type dependent effects of Pten loss in the adult brain, including increased astrocyte proliferation that may render astroglial cells susceptible to neoplastic transformation or malignant progression.




This article has been cited by other articles:


Home page
 Genes Dev.Home page
A. Iwanami, T. F. Cloughesy, and P. S. Mischel
Striking the balance between PTEN and PDK1: it all depends on the cell context
Genes & Dev., August 1, 2009; 23(15): 1699 - 1704.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
N. Chalhoub, G. Zhu, X. Zhu, and S. J. Baker
Cell type specificity of PI3K signaling in Pdk1- and Pten-deficient brains
Genes & Dev., July 15, 2009; 23(14): 1619 - 1624.
[Abstract] [Full Text] [PDF]

Home page
 DMMHome page
M. C. Ljungberg, C. N. Sunnen, J. N. Lugo, A. E. Anderson, and G. D'Arcangelo
Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia
Dis. Model. Mech., July 1, 2009; 2(7-8): 389 - 398.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
C. Gregorian, J. Nakashima, J. Le Belle, J. Ohab, R. Kim, A. Liu, K. B. Smith, M. Groszer, A. D. Garcia, M. V. Sofroniew, et al.
Pten Deletion in Adult Neural Stem/Progenitor Cells Enhances Constitutive Neurogenesis
J. Neurosci., February 11, 2009; 29(6): 1874 - 1886.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. Codeluppi, C. I. Svensson, M. P. Hefferan, F. Valencia, M. D. Silldorff, M. Oshiro, M. Marsala, and E. B. Pasquale
The Rheb-mTOR Pathway Is Upregulated in Reactive Astrocytes of the Injured Spinal Cord
J. Neurosci., January 28, 2009; 29(4): 1093 - 1104.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Broniscer, S. J. Baker, C. F. Stewart, T. E. Merchant, F. H. Laningham, P. Schaiquevich, M. Kocak, E. B. Morris, R. Endersby, D. W. Ellison, et al.
Phase I and Pharmacokinetic Studies of Erlotinib Administered Concurrently with Radiotherapy for Children, Adolescents, and Young Adults with High-Grade Glioma
Clin. Cancer Res., January 15, 2009; 15(2): 701 - 707.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Rahdar, T. Inoue, T. Meyer, J. Zhang, F. Vazquez, and P. N. Devreotes
A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN
PNAS, January 13, 2009; 106(2): 480 - 485.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. Liu, B. Tian, M. Gearing, S. Hunter, K. Ye, and Z. Mao
Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion
PNAS, May 27, 2008; 105(21): 7570 - 7575.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C.-H. Kwon, D. Zhao, J. Chen, S. Alcantara, Y. Li, D. K. Burns, R. P. Mason, E. Y.-H. P. Lee, H. Wu, and L. F. Parada
Pten Haploinsufficiency Accelerates Formation of High-Grade Astrocytomas
Cancer Res., May 1, 2008; 68(9): 3286 - 3294.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
E. C. Torchia, K. Boyd, J. E. Rehg, C. Qu, and S. J. Baker
EWS/FLI-1 Induces Rapid Onset of Myeloid/Erythroid Leukemia in Mice
Mol. Cell. Biol., November 15, 2007; 27(22): 7918 - 7934.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
F. B. Furnari, T. Fenton, R. M. Bachoo, A. Mukasa, J. M. Stommel, A. Stegh, W. C. Hahn, K. L. Ligon, D. N. Louis, C. Brennan, et al.
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Genes & Dev., November 1, 2007; 21(21): 2683 - 2710.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. K. Sandsmark, H. Zhang, B. Hegedus, C. L. Pelletier, J. D. Weber, and D. H. Gutmann
Nucleophosmin Mediates Mammalian Target of Rapamycin-Dependent Actin Cytoskeleton Dynamics and Proliferation in Neurofibromin-Deficient Astrocytes
Cancer Res., May 15, 2007; 67(10): 4790 - 4799.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Kawaguchi, Y. Yamashita, M. Kanamori, R. Endersby, K. S. Bankiewicz, S. J. Baker, G. Bergers, and R. O. Pieper
The PTEN/Akt Pathway Dictates the Direct {alpha}V{beta}3-Dependent Growth-Inhibitory Action of an Active Fragment of Tumstatin in Glioma Cells In vitro and In vivo
Cancer Res., December 1, 2006; 66(23): 11331 - 11340.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Q. Wei, L. Clarke, D. K. Scheidenhelm, B. Qian, A. Tong, N. Sabha, Z. Karim, N. A. Bock, R. Reti, R. Swoboda, et al.
High-grade glioma formation results from postnatal pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model.
Cancer Res., August 1, 2006; 66(15): 7429 - 7437.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
G. Otaegi, M. J. Yusta-Boyo, E. Vergano-Vera, H. R. Mendez-Gomez, A. C. Carrera, J. L. Abad, M. Gonzalez, E. J. de la Rosa, C. Vicario-Abejon, and F. de Pablo
Modulation of the PI 3-kinase-Akt signalling pathway by IGF-I and PTEN regulates the differentiation of neural stem/precursor cells
J. Cell Sci., July 1, 2006; 119(13): 2739 - 2748.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
X. Zhang, F. Li, A. Bulloj, Y.-w. Zhang, G. Tong, Z. Zhang, F.-F. Liao, and H. Xu
Tumor-suppressor PTEN affects tau phosphorylation, aggregation, and binding to microtubules
FASEB J, June 1, 2006; 20(8): 1272 - 1274.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Groszer, R. Erickson, D. D. Scripture-Adams, J. D. Dougherty, J. Le Belle, J. A. Zack, D. H. Geschwind, X. Liu, H. I. Kornblum, and H. Wu
PTEN negatively regulates neural stem cell self-renewal by modulating G0-G1 cell cycle entry
PNAS, January 3, 2006; 103(1): 111 - 116.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
Y. Zhu, T. Harada, L. Liu, M. E. Lush, F. Guignard, C. Harada, D. K. Burns, M. L. Bajenaru, D. H. Gutmann, and L. F. Parada
Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation
Development, December 15, 2005; 132(24): 5577 - 5588.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Ma, A. C. Ziel-van der Made, B. Autar, H. A. van der Korput, M. Vermeij, P. van Duijn, K. B. Cleutjens, R. de Krijger, P. Krimpenfort, A. Berns, et al.
Targeted Biallelic Inactivation of Pten in the Mouse Prostate Leads to Prostate Cancer Accompanied by Increased Epithelial Cell Proliferation but not by Reduced Apoptosis
Cancer Res., July 1, 2005; 65(13): 5730 - 5739.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.